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Abstract
Cardiovascular disease (CVD) risk factors, such as increased body fat, dyslipidemia, and high
sensitivity C-reactive protein (CRP) levels are intensified in postmenopausal women. CRP has
been reported as an independent indicator of risk for cardiovascular events. CRP is affected by
multiple factors such as age, race, body mass index (BMI), and physical activity level. The
purpose of this study was to compare the effects of an exercise intervention on traditional (BMI,
percent body fat, waist circumference, physical activity level) and non-traditional (CRP) risk
factors for cardiovascular disease to a dietary intervention program in sedentary, postmenopausal
women. Twenty apparently healthy postmenopausal women were randomly assigned to a diet
intervention group (DI) or an exercise intervention group (EXI) for a period of 9 weeks. DI
participants reported once a week for a body weight measurement and EXI participants were
asked to attend 3 exercise sessions per week that were 45-55 minute sessions (cardiovascular and
resistance training exercises). There were no significant effects of time or treatment intervention,
or a time x treatment interaction on CRP levels (p=0.077, p<0.05). However, there was a
significant change (-4.45 kg) in body weight (p=0.000, p< 0.05) and (-1.1 kg) change in fat free
mass (p=0.041, p<0.05) in the DI group. Body weight, FFM, and waist circumference all
decreased significantly in the DI group; however, decreases in these variables did not appear to
precipitate significant changes in CRP. It is possible that a greater degree of weight loss (over a
longer duration) may be necessary to decrease CRP levels. There was no significance between
EXI and dependant variables, including CRP, also suggesting that greater intensity or longer
intervention duration may be necessary to affect dependant variables through exercise.

vi

Chapter 1
Introduction
Cardiovascular disease (CVD) is the major cause of death among the U.S. population.8, 16,
33

With aging, the risk of CVD proportionally increases; however, women are affected by CVD

10 years after men.25,33 Clinical diagnosis for CVD in women is more challenging than men
because women do not present typical signs of chest pain or ischemia. CVD death rates are 34%
higher in black women than white women due to the higher prevalence of CVD risk factors, such
as diabetes and obesity.23,33 Risk factors for CVD in women are smoking (leading cause),
hypertension, dyslipidemia, diabetes mellitus, obesity, sedentary lifestyle, and menopause.6, 25, 33,
44, 46

Hypertension, dyslipidemia, and obesity are risk factors for both men and women; 60% of

white women and 79% of black women over the age of 45 are classified as hypertensive (systolic
blood pressure ≥140 mm Hg or diastolic blood pressure ≥ 90 mm Hg).33 Regarding increased
total cholesterol, 55% of women over 55 years old are classified as high (≥ 240 mg/dL). Low
HDL level is a stronger CVD predictor for women than men; as, a 1% increase in HDL is
associated with 3-5% decrease in risk for women. 33, 46 Obesity, especially increased abdominal
adiposity, is a risk factor for CVD in women. The prevalence of obesity has increased over the
past decade and currently one out of three women is classified as obese. Obesity is a parallel
factor to sedentary lifestyle, and studies have shown that moderate physical activity reduces the
risk of CVD by 50% in women. Schenck46 reported in 2009 that 30% of women are overweight
and 27% are classified as obese, and the risk for CVD in obese women increases 3-fold compared
to lean women. 20, 25, 33
Postmenopausal women experience similar risk factors as men; however, certain CVD
risk factors are intensified in postmenopausal women.44, 46 Redistribution of fat from gynoid to
android pattern, increased body fat, increased blood pressure, and dyslipidemia amplify CVD
risk.4, 41 Menopause decreases the estrogen levels and increases testosterone levels in
postmenopausal women, negatively affecting cardiovascular functions and metabolism resulting
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in an increase risk for CVD event, such as dyslipidemia resulting from increased testosterone. 41
A 2-fold increase for CVD occurs with low sex hormone binding globulin or high free androgen
index value. 41
In addition to the serum cholesterol risk factors, abnormal lipoprotein, C-reactive protein
(CRP) and interleukin-6 levels are known risk factors for CVD in women. 3, 13, 15, 39, 46
Inflammation markers have been determined to have a significant role in the development of
atherosclerosis and CVD, but the relationship between the inflammation process and CVD is
complex.4, 16, 22 In response to tissue inflammation, CRP is stimulated by interleukin-6,
interleukin-1, and tumor neurosis factor.22 This response occurs when activated immune cells in
the plaque produce inflammatory cytokines, stimulating the production of substantial amounts of
interleukin-6. Interleukin-6, in response, stimulates the production of large amounts of acutephase reactants (C-reactive protein, serum amyloid A, and fibrinogen) in the liver. Plasma
concentration of CRP can increase 100-fold after acute inflammatory stimulus.5, 11, 42 According
to Hansson,16 cytokines have important biologic effects at all steps; however, their amplification
at each step of the cascade makes the measurement of downstream mediators such as CRP
particularly useful for clinical diagnosis.
CRP is an inflammatory marker that has been investigated regarding its influence on an
individual’s risk for CVD. Several investigators have suggested that CRP levels reflect the
inflammation status, which is related to the severity of atherosclerosis.5, 11, 22, 42 CRP is an
independent indicator of risk for stroke, peripheral vascular disease, and vascular death among
healthy men and women without any known vascular diseases and is a stronger predictor for CV
events compared to LDL-C levels. 5, 11, 42, 43 Currently practitioners consider CRP value of less
than 2 mg/L as healthy, and individuals who have CRP levels of 5mg/L or greater may be at an
increased risk for a cardiac event within six months.22, 26
CRP is affected by multiple factors such as age, race, body mass index (BMI), and
physical activity level.1, 3, 4, 9, 13, 14, 17, 18, 22, 28, 49, 52, 53 CRP levels have been shown to increase with
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age; therefore, BMI and physical activity level are needed to counteract the natural rise in CRP
levels.22, 28 CRP is highly correlated with BMI and several studies have reported a strong
correlation between total fat mass and visceral fat and CRP.17, 18, 23, 52 Heilbroon17 and Williams53
have reported that subjects with a BMI >30 kg/m2 had elevated CRP levels and CRP levels were
found to be 270% higher in individuals in the top quintile of BMI compared to those in the
bottom quintile. In addition to BMI, a direct relationship between elevated CRP levels and
abdominal fat distribution via waist circumference measurement has been documented.17, 18, 52 A
waist circumference greater than 88 centimeters can be associated with a higher BMI and higher
risk for CVD due to increased visceral fat and increase in serum resistin.18, 51 Finally, increased
physical activity levels are related to decreased fat and lower BMI resulting in decreased CPR
levels.1, 3, 14, 29, 49
A review of current literature indicates that there is an inverse relationship between
physical activity and CRP levels. Specifically, investigators have observed the lowest CRP levels
in individuals with the highest activity levels.1,3,10,14 Physical activity is associated with a lower
risk of subsequent CVD events; however, physical activity in young adulthood was not a
predictor of CVD risk several decades later. 10 There is an inverse relationship between physical
activity during middle age and CVD risk; therefore, it is necessary to maintain physical activity
levels with aging to minimize a cardiovascular event. Along with an inverse relationship between
physical activity level and CRP levels being reported, there is an inverse association between
intensity and/or frequency of exercise with CRP levels. CRP levels decrease with more vigorous
exercise or more frequent exercise.1, 3, 49 Cross sectional studies used questionnaires to determine
participants’ physical activity frequency and intensity, and the 6-minute walk test, treadmill
VO2max test, and cycle ergometry VO2max test were used to determine physical activity level.1, 2, 3, 9,
14, 29, 49

Higher VO2max measurements were associated with lower CRP levels.3,29 The dose-

response relationship utilizes frequency and/or intensity of physical activity to determine the
decrease for CVD risk.37
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Multiple studies have shown that with weight loss and exercise, CRP levels decrease in
proportion to weight loss.30, 38, 40, 45 Increased physical activity promotes decreased weight, body
fat percentage, adipose tissue, and BMI resulting in decreased CRP levels.45 Cross sectional
studies used questionnaires to determine participants’ physical activity frequency and intensity or
participants’ complete a submaximal treadmill test to determine VO 2max.3, 31, 40 Intervention
studies consisting of aerobic activity 3 days/week through group exercise classes, treadmill, or
cycling for 30-60 minutes at 60% VO2max or between 60-80% peak heart rate resulted in a
decrease in body weight, percentage body fat, fat mass, fat free mass, visceral adipose tissue, and
decrease in CRP levels was observed, however VO2max did not change after weight loss.30, 38, 45
The consensus of currently published studies indicates that CRP will decrease as a result
of weight loss that is achieved through dietary changes. Dietary interventions that have produced
weight loss and decreased CRP values have been as short of one month and as long as 18 months
in duration. The majority of diet interventions reviewed consisted of a hypocaloric diet for a
period of 12 weeks with obese women as the study population.10, 14, 35, 36, 49 Previous studies have
solely investigated changes of CRP levels resulting from weight loss through dietary alterations
or weight loss through exercise. It is unknown if exercise without weight loss alone has an effect
on CRP levels in sedentary, postmenopausal women. The purpose of this study was to compare
the effects of an exercise intervention versus a dietary intervention on traditional (BMI, percent
body fat, waist circumference, physical activity level) and non-traditional (CRP) risk factors for
cardiovascular disease in sedentary, post menopausal women.

Chapter II
Review of Literature
Increased CRP levels have been reported as an independent predictor for CVD.54 Risk
factors that affect CRP are age, waist circumference, BMI, race, cholesterol, blood pressure, and
physical activity level.4, 13, 23, 25, 39 Studies have been conducted on the obese, postmenopausal
population and older men and women to determine if weight loss through diet, physical activity,
and/or physical activity with weight loss affects CRP levels. Weight loss through low calorie diet
has been shown to reduce CRP levels in obese, postmenopausal women since the in CRP levels is
primarily associated with loss in fat mass during weight loss.50 Also, physical activity has been
associated with decreased CRP levels and reduced risk of CVD. There is an inverse relationship
between activity level and CVD risk and CRP level; as activity levels increase, CRP levels
decrease in both genders.3, 10, 49 Along with decreased inflammatory markers, decreased weight,
body fat percentage, adipose tissue, and BMI result from increased physical activity.8, 45
Lifestyles changes, especially physical activity and diet, can promote significant improvements of
CVD risk factors, such as decreased CRP levels.
Table 1: Risk Factors for Cardiovascular Disease.
Article
Problem/Question
Participants
Studied
Cardiovascular
Focus on
Review paper.
disease in
epidemiology and
postmenopausal
impact of CVD on
women: myths and
women and review
reality (Lewis, 2002). risk factors.

Procedures
Review paper.

Menopause and
cardiovascular
disease: the evidence
(Romano, 2007).

To discuss
menopause of a risk
factor for CVD.

Review paper.

Review paper.

Risk factor for
cardiovascular
disease in women
(SchenckGustafsson, 2009).

To discuss CVD risk
factors in women.

Review paper.

Review paper.

Findings
Positive lifestyle
(physical activity,
weight control,
healthy diet, and
smoking cessation)
reduce the
prevalence of CVD.
Menopause is
associated with a
significant increase
in CVD risk due to
detrimental effects
of estrogen
deficiency.
CVD is presented
later in life for
women and are more
likely to be suffer
with co-morbidities,
such as high blood
pressure and
diabetes.
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Article

Participants

Procedures

Findings

239 women and 265
men.

Blood samples were
collected.

To examine the
relationship of plasma
androgens and
estrogens with risk of
CVD in
postmenopausal
women.

28,345
postmenopausal
women.

Low dose of aspirin
and vitamin E were
administered; blood
samples were
collected to analyze
estradiol levels.

Regional fat
distribution in
women and risk of
cardiovascular
disease (Williams,
1997).

To determine which
fat-distribution
variables (arm fat, leg
fat, trunk fat,
intraabdominal
adipose fat, or
subcutaneous adipose
fat) have independent
relations with CVD
risk.

224 healthy white
women; 138
premenopausal and
86 postmenopausal
(17-77 years old).

Obesity as an
independent risk
factor of
cardiovascular
disease (Hubert,
1983).

To investigate to
relationship between
the degree of obesity
and the incidence of
CVD in men and
women.

5209 participants
(2252 men and 2818
women); 28-62 years
old.

Association between
C-reactive protein,
metabolic
cardiovascular risks,
obesity, and oral
contraceptive use in
young adults
(Williams, 2004).
Elevated C-reactive
protein levels in
overweight and obese
adults (Visser, 1999).

To determine the
relationship between
levels of CRP, CV
risk factors, and oral
contraceptive.

822 men and
women; 26 years
old.

To test whether
overweight and
obesity are associated
with inflammation as
measured by CRP.
To determine the
relationship between
CRP in blood
pressure in women
and determine
whether blood
pressure is an
independent
determinant of CRP
levels.

16,616 men and
women.

Cross-sectional
design that analyzed
body fat via CT
(abdominal), UWW
(bone density),
DEXA (total body),
height and weight
were measured to
nearest 0.5cm.
Blood sample (after
12 hour fast) to
collect lipid
measures and blood
pressure was
performed.
Height and weight
were measured to
calculate BMI,
blood pressure,
serum cholesterol,
blood glucose, and
smoking status were
all measured.
Cross sectional
study, Blood
samples were
collected,
anthropometric
measurements and
blood pressure were
measured.
BMI, waist
circumference were
measured. Blood
samples collected to
measure CRP.
Blood samples were
collected, blood
pressure and BMI
were measured.

Elevated levels of
inflammatory
makers, especially
CRP, indicate risk of
CVD.
Low sex hormone
binging globulin or
high free androgen
index is associated
with increased risk
of CVD events.
Low SHBG
increased CVD 2fold.
Intraabdominal
adipose fat and trunk
fat were positively
related to CVD risk
factors.

Inflammatory
markers and the risk
of coronary heart
disease in men and
women (Pai, 2004).
Sex hormone levels
and risk of
cardiovascular events
in postmenopausal
women (Rexrode,
2003).

Blood pressure, Creactive protein, and
risk of future
cardiovascular events
(Blake, 2003).

Problem/Question
Studied
To investigate
inflammatory markers
as predictors of CVD.

15,215 women over
45 years old.

The degree of
obesity in men and
women is an
important long term
predictor of CVD
incident.

Independent
relationship between
CRP and obesity as
cofounding risk
factors of CVD.

Higher BMI is
associated with
elevated CRP levels.

Inconclusive on
whether blood
pressure is a
determinant of CRP
levels; however BP
and CRP were
confirmed as risk
factors for CVD.

7
Article
Distribution and
correlates of Creactive protein
concentrations
among adult US
women (Ford, 2004).
Race and gender
differences in Creactive protein
levels (Khera, 2005).

Interrelationships
among circulating
Interlukin-6, Creactive protein, and
traditional
cardiovascular risk
factors in women
(Bermudez, 2002).
Physical activity and
cardiovascular
disease risk in
middle-aged and
older women (Sesso,
1999).

Problem/Question
Studied
To understand the
distribution among
CRP concentrations
among women.

Participants

Procedures

2,205 women >20
years old.

Questionnaires
completed. Blood
samples were
collected.

To determine whether
there are race and
gender differences in
CRP levels.

2,749 white and
black men and
women (age 30-65
years old).

To determine the
relationship of IL-6,
CRP, and CVD risk
factors in healthy
women.

340 postmenopausal
women (mean age
60).

Weight, heart rate,
blood pressure, and
BMI were measured.
Blood samples were
collected after an
overnight fast.
Cross-sectional
study; health history
questionnaires were
completed, blood
samples were
analyzed for IL-6
and CRP.

To investigate
whether physical
activity during middle
and late years alters
the risk of CVD.

2,363 female
subjects (37-69 years
old).

Cross sectional
design utilizing
questionnaires that
reported the number
of hours spent
walking flights of
stairs climbed, city
blocks walked, and
sports participated
weekly. Body
weight and BMI
were calculated to
determine energy
expenditure.

Findings
There was an
association between
CRP and BMI, waist
circumference,
cholesterol, and
blood pressure.
Black women have
higher CRP levels
than white women.

Age, BMI, blood
pressure smoking
status, and HDL
levels are associated
with CRP levels.

Walking may
decrease CVD risk
by 33%. Overall,
there is no
association of
physical activity and
CVD risk in women.
The benefit of
walking was found
in lean women only
(BMI < 23).

There are multiple factors that have been shown to affect C-reactive protein (CRP) levels
and/or risk of cardiovascular disease (CVD) in women. CRP levels and CVD have a direct
relationship given that increased CRP levels have been reported as an independent predictor for
CVD.54 There are risk factors that affect CRP while in effect increase the risk of CVD, such as
age, waist circumference, BMI, race, cholesterol, blood pressure, and physical activity level. 4, 13,
23, 25, 39

Non-modifiable risk factors for elevated CRP levels are age and ethnicity. According to

Rexrode14 and Rosano,44 as women age and menopause occurs, there is a decrease in estrogen
levels, decrease in sex hormone binding globulin and increase in free androgen index while
augments the risk of CVD. Modifiable risk factors, such as waist circumference, BMI, and
physical activity level, affect the risk of CVD in men and women. Distribution of fat alters from
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gyniod to android placing more fat in the abdominal area as women age. Williams 54 reported that
an increase in intraabdominal adipose fat and trunk fat, measured by waist circumference,
enhance the risk of CVD in women. In addition to waist circumference, elevated BMI has is
associated with elevated CRP levels and an independent predictor of CVD in both men and
women. 4, 13, 20, 25, 39, 52, 54 Regarding race, it has been shown that black women have increased BMI
and CRP levels compared to white women, increasing their risk for CVD.23 Finally, elevated
total serum cholesterol in women is associated with elevated CRP levels. Total serum cholesterol
is related to increased BMI and increased intraabdominal abdominal fat.13
The literature was consistent when observing age, waist circumference, BMI, race, and
cholesterol. However, there are inconclusive research regarding blood pressure and physical
activity level and their effects on CRP levels and/or CVD risk. Literature has shown that within
postmenopausal women, increased blood pressure, specifically systolic blood pressure
measurement, increase risk for CVD risk, but there is controversy research if blood pressure is a
determinant of CRP level.4, 46 Bermudez4 stated that elevated blood pressure is associated with
elevated CRP levels, whereas Blake6 reported that there is inconclusive evidence that blood
pressure is a determinant for CRP level. Finally, physical activity and its effects on CRP levels
will be discussed in for detail in Table 3, but as a risk factor for postmenopausal women, Lewis25
reported 80% lower risk for a cardiovascular risk and decreased CPR level if moderate to
vigorous activity was performed for 30 minutes most days of the week, while Sesso47 reported
that light activity, such as walking, can reduce the CVD risk by 33% but the relationship was not
significant enough to state that physical activity is associated to CVD.
Table 2: Effects of C-Reactive Protein with Weight Loss through Diet
Article
Problem/Question
Participants
Studied
The effect of weight
To test the
Review paper.
loss on C-reactive
hypothesis that
protein (Selvin,
weight loss is
2007).
directly related to a
decline in CPR level.

Procedures

Findings

A review of weight
loss intervention
studies that included
lifestyle, diet and/or
exercise
interventions.

A decline in CRP
level is associated
with weight loss by
way of lifestyle or
surgical intervention.
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Article
C-reactive protein
and coronary artery
disease: influence of
obesity, caloric
restriction and
weight loss
(Heilbronn, 2002).

Problem/Question
Studied
To determine whether
particular dietary
macronutrient or
micronutrients alter
IL-6 and/or CRP
level.

Participants

Procedures

Review paper.

Review paper.

Findings
CRP is a predictor of
acute vascular events
because
inflammatory
penetration
expresses IL-6
which stimulates
CRP.
All diets resulted in
a decrease in Creactive protein
levels; however, the
statin diet resulted in
the greatest
reduction.

Effects of a dietary
portfolio of
cholesterol-lowering
foods vs lovastain on
serum lipids and Creactive protein
(Jenkins, 2003).

To determine the
dose-response
relationship of nuts
and their advantage in
a low-saturated fat
therapeutic diet.

Forty-six healthy,
hyperlipidemic
adults; 25 men and
21 postmenopausal
women.

1 m. intervention;
body weight was
measured weekly
and blood samples
were obtained every
2 weeks after a 12hr fast; 1 of 3 diets
were assigned (very
low in saturated fat,
very low in
saturated fat plus
lovastatin, high in
plant sterols).

Effect of high-fiber
diet vs a fibersupplemented diet on
C-reactive protein
level (King, 2007).

To examine the
reduction in
inflammation from a
diet supplemented
with fiber compared
to a diet naturally
high in fiber.

35 participants (28
women, 7 men; 18
lean normotensive,
17 obese
hypertensive).

Both diets
demonstrated a
decrease in CRP
levels, however,
CRP decreased
significantly in lean
group but no
significance in obese
group.

Relation between a
deit with a high
glycemic load and
plasma concentration
of high-sensitivity Creactive protein in
middle-aged women
(Liu, 2002).

To examine whether a
high dietary glycemic
load was associated
with elevated CRP
concentration and
whether this
association was
modified by body
mass index.
To determine the
effects of dynamic
weight loss on CRP in
healthy, obese
women.

244 apparently
healthy women.

Crossover
intervention of highfiber DASH diet or
fiber-supplemented
diet; photographs
were taken for 3
days of each 3 week
diet; weekly urine
samples, weight
measurement, and
diet consulting.
Cross sectional
design; blood draw
was done and a food
frequency
questionnaire was
completed.

Eighty-three
nonsmoking, healthy,
obese women.

12 wk intervention
(every 4 weeks after
a 12-hr fast); weight
recorded and blood
drawn.

CRP was lowered in
proportion to weight
loss.

To examine the
relations among body
fat, fat distribution,
and CRP levels.

Twenty-five obese,
postmenopausal
women.

14 m. intervention
(blood was tested
after 12-hr fast and
3 days of
standardized meals);
1200 kcal/day. One
group received a
modified fasting
supplement.

Losses of fat mass in
obese,
postmenopausal
women were
associated with
proportional
reductions in CRP
levels.

Energy restriction
and weight loss on
very-low-fat diets
reduce C-reactive
protein concentration
in obese, healthy
women (Heilbronn,
2001)
Weight loss reduces
C-reactive protein
levels in obese
postmenopausal
women (Tchernof,
2001).

Dietary glycemic
index load is
significantly and
positively associated
with CRP levels in
healthy middle-aged
women.

10
Article
Diet-induced weight
loss is associated
with decreases in
plasma serum
Amyloid A and Creactive protein
independent of
dietary
macronutrient
composition in obese
subjects (O’Brien,
2005).
Effect of an energyrestricted, highprotein, low-fat diet
relative to a
conventional highcarbohydrate, lowfat diet on weight
loss, body
composition,
nutritional status,
and markers of
cardiovascular health
in obese women
(Noakes, 2005).

Problem/Question
Studied
To examine the
influence of
macronutrient
composition of
weight loss on levels
of CRP.

Participants

Procedures

Findings

41 obese women.

3 m. intervention;
1200 kcal/day lowfat diet (AHA step
1) or very lowcarbohydrate diet;
weight and blood
samples were
completed for
baseline and at 3
months.

There was a greater
reduction in CRP
with the very lowcarbohydrate diet
compared to the lowfat diet.

To evaluate the
effects of a diet with a
high ratio of protein
to carbohydrate
during weight loss on
body composition,
CVD risk, nutritional
status, and markers of
bone turnover and
renal function in
overweight women.

100 obese women.

Hypocaloric highprotein, low-fat diet
resulted in
nutritional and
metabolic (CRP
decreased with
weight loss) benefits
that are greater than
the highcarbohydrate diet.

Long-term effects of
high-protein, lowcarbohydrate diet on
weight control and
cardiovascular risk
markers in obese
hyperinsulemnic
subjects
(Brinkworth, 2004).

To compare long term
compliance and
effects of two low fat
diets differing in
carbohydrates to
protein ratio on body
composition and
biomarkers of CVD
risk in obese subjects
with
hyperinsulinemia.

Fifty-eight obese,
nondiabetic subjects
with
hyperinsulinemia; 13
males and 45
females.

Diet-induced weight
loss, exercise, and
chronic
inflammation in
older, obese adults: a
randomized
controlled clinical
trial (Nicklas, 2004).

To determine the
independent and
combined effects of
diet-induced weight
loss and exercise on
the markers of
chronic inflammation.

316 sedentary,
overweight men and
women (>60 years).

12 wk intervention;
5600 kJ diet of highprotein or highcarbohydrate;
consultation with a
dietian every 4
weeks and
completed a food
intake log; fasting
blood samples were
obtained at baseline,
wk 4,8, and 12;
weight was
measured every 14
days (after fasting
overnight).
68 wk intervention
(12 wk of energy
restriction, 4 wk of
energy balance, 52
wk without
counseling); body
weight and blood
drawn at baseline,
wk 16, and wk 68.
Two diets were
distributed (standard
protein intake or
high protein intake).
18 m. intervention;
diet-induced weight
loss (decease by
5%), exercise (3
days/week for 1
hour sessions), or
diet and exercise;
blood samples (after
fast),
anthropometric
measurements.

Both diets were
equally as effective
in weight loss and
decrease in CRP
compared to
conventional weight
loss approaches.

Weight loss via diet
reduced overall
inflammation.
Exercise training did
not have an effect on
inflammatory
markers.
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Article
Effects of
hypocaloric diet and
exercise training on
inflammation and
adipocyte lipolysis in
obese
postmenopausal
women (You, 2004).

Problem/Question
Studied
To determine whether
a hypocaloric diet
with and without
exercise training is
effective in reducing
plasma C-reactive
protein.

Participants
34 healthy,
nonsmoking,
overweight/obese
postmenopausal
women.

Procedures
6 m. intervention;
body weight was
measured, food
records and diet
instruction to elicit
0.5-1.0kg/wk were
done weekly; diet
and exercise group
also walked 3d/wk
at target heart rate.

Findings
CRP decreased with
diet and exercise but
not diet alone, even
though both groups
lost similar amounts
of weight and
adipose tissue.

C-reactive protein is a predictor of acute vascular events due to the stimulation of CRP by
interleukin-6 (IL-6) during the inflammation process.17 Among the population of in obese,
postmenopausal women, weight loss has been shown to reduce CRP levels.34, 48, 50 Tchernof 50
reported that the reduction in CRP levels is primarily associated with loss in fat mass [adipose
tissue] during weight loss. There have been numerous studies conducted researching different
types of weight loss regimes that have resulted in lower CRP levels from baseline levels.7, 18, 21, 24,
27, 34, 35, 36, 55

There are discrepancies among studies regarding diet and exercise versus diet alone
interventions. The decrease in CRP level and reduction of weight through diet were proportion.18
Contrary to Heilbronn,18 CRP levels did not decrease with weight loss and fat loss [adipose
tissue] through diet alone; however CRP levels did decrease with weight loss and fat loss
[adipose tissue] through diet and exercise.55
Table 3: Effects of C-Reactive Protein through Physical Activity
Article
Problem/Question
Participants
Studied
Physical activity
To review and
Meta-analysis.
decreases
quantify the dosecardiovascular
response relationship
disease risk in
of physical activity in
women (Oguma,
healthy women on
2004).
CVD outcomes.

Procedures

Findings

Studies reviewed
inclusion criteria was
data on women,
assessed physical
activity, and provided
information on
relative risk of CVD.

Walking 1hour/week
was associated with
reduced risk of CVD
outcome. Physical
activity was
association with
reduced risk of CVD
among women in a
dose-response
relationship.
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Article
Cross-sectional and
prospective
relationships of
Interleukin-6 and Creactive protein
with physical
performance in
elderly persons
(Taaffe, 2000).

Problem/Question
Studied
To examine the crosssectional and
perspective
relationships between
markers of
inflammation with
several measures of
physical performance
in older persons aged
70 to 79 years.

Participants

Procedures

880 men and
women, 65 yr or
older.

Blood samples were
collected (nonfasting); physical
function tests were
performed (baseline
and 7 yrs later);
anthropometric
measurements and
medications were
recorded.
10 yr study; subjects
completed a
mailed baseline
questionnaire on
sociodemographics,
health habits, and
medical history;
participated in the
trial after a 3-month
run-in phase; followup surveys asking
about treatment
compliance,
risk factors, and
endpoints of interest
were mailed every 6
months during the
first year and
annually.
At baseline, medical
history, medication,
physical activity
level, fasting blood
samples, and
anthropometric
measurements were
collected;
measurements were
obtained 3 yr later.
Cross sectional study;
stage I, in-home
interview regarding
demographics, health
status, health
behaviors; stage II,
conducted within 4
wks of stage I.

Past physical
activity, current
physical activity,
and risk of coronary
heart disease
(Conroy, 2005).

To examine the
relationship between
physical activity
during young
adulthood and middle
age, and physical
activity during each
time period and CHD
occurring in middleaged or older.

Cohort study of
37,169 healthy U.S.
female health
professionals, age 45
yr or older.

Association
between physical
activity and markers
of inflammation in a
healthy elderly
population
(Geffken, 2001).

To measure the
association between
self reported physical
activity with several
markers of
inflammation in a
population-based
elderly cohort.

5,888 participants
(male and female);
2,501 diagnosed
with clinical CVD
and 3,837 did not
have CVD.

Relationship
between physical
activity and
inflammation
among apparently
healthy middle-aged
and older US adults
(Abramson, 2002).

To examine the
association of
physical activity with
3 markers of
inflammation in a
representative sample
of apparently healthy
US adults.

3,638 apparently
healthy US men and
women 40 yr and
older.

Low cardiovascular
fitness is associated
with elevated Creactive protein
levels in women
with Type 2
diabetes
(McGavock, 2004).

To examine
differences in
markers of CVD in
women with type 2
diabetes.

28 women with type
2 diabetes but absent
of CVD events with
low or average
cardiorespiratory
fitness levels.

Cross sectional study.
Physical examination
and cycle ergometry
test were performed
to determine
VO2max. Blood
samples were
collected after an
overnight fast along
with an EKG.

Findings
Higher IL-6 and
CRP levels in those
less active; CRP was
related to increased
walking speed and
grip strength;
signature time and
chair-rise ability
were not associated
with changes in
CRP.
Physical activity at
study baseline
was associated with
a lower risk of
subsequent CHD
events; however,
physical activity in
young adulthood was
not a predictor of
CHD risk several
decades later. There
is an inverse
relationship between
physical activity
during
middle age and CHD
risk.

Physical activity
level is associated
with significantly
lower levels of CRP,
independent of
known CVD risk
factors.

A higher frequency
of physical activity
was associated with
lower CRP levels.

Low
cardiorespiratory
fitness is associated
with elevated CRP
levels.
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Article

Participants

Procedures

Findings

3,075 black and
white men and
women (70-79 years
old).

Cross sectional study.
Questionnaires
determines physical
activity level and
blood sample
analyzed
inflammatory marker
levels.

Inflammatory
markers are lower in
older adults with
higher levels of
exercise.

To examine the
association between
physical activity and
CRP levels.

1.732 men and 1.101
women.

There is an inverse
relationship between
physical activity and
inflammatory
biomarkers.

C-reactive protein is
inversely related to
fitness in middleaged subjects
(Aronson, 2004).

To examine the
relationship between
physical fitness and
CRP levels in middleaged subjects.

892 conservative
middle aged
subjects.

Physical activity an
d cardiovascular
disease risk in
middle-aged and
older women
(Sesso, 1999).

To investigate
whether physical
activity during middle
and late years alters
the risk of CVD.

2,363 female
subjects (37-69 years
old).

Cross sectional study.
Blood samples to
evaluate CRP and
lipids; data on age,
smoking status, and
diabetic status;
physical activity level
was self reported.
Cross sectional study
where body mass
index was calculated,
blood samples were
collected after a 12 hr
fast, and fitness level
was calculated
through a VO2max test
using the Bruce
protocol.
Cross sectional study.
Questionnaires
reported the number
of hours spent
walking flights of
stairs climbed, city
blocks walked, and
sports participated
weekly. Body weight
and BMI were
calculated to
determine energy
expenditure.

Physical activity,
exercise, and
inflammatory
markers in older
adults: Findings
from the health,
aging, and body
composition study
(Colbert, 2004).
Effect of physical
activity on serum Creactive protein
(Albert, 2004).

Problem/Question
Studied
To examine the
association between
physical activity and
inflammatory
markers.

CRP concentration
decreased with
increasing levels of
fitness and decreased
BMI.

Walking and/or a
lower BMI were
inversely related to
CVD risk. Overall,
there is no
association of
physical activity and
CVD risk in women.

The literature reviewed examining the effects of physical activity on CRP levels were
cross-sectional studies. Most of the studies reviewed used both men and women over the age of
40 years old as participants. There was consistent evidence that physical activity was associated
with decrease in CRP levels and lower risk of CVD. There is an inverse relationship between
activity level and CVD risk and CRP level; as activity levels increase, CRP levels decrease.3, 10, 49
This relationship was demonstrated through three different methods of analyzing physical activity
level. The cross sectional studies that used questionnaires to determine participants’ physical
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activity level concluded that increased physical activity resulted in lower CRP levels.1,2,3,9,14
Other protocols used to determine physical activity level were 6-minute walk test, treadmill
VO2max test, and cycle ergometer VO2max test. Taffee49 concluded that increased activity level is
associated with lower CPR levels after a 6-minute walk test to men and women over the age of 65
was administered. The Bruce treadmill protocol was utilized to measure the VO 2max in middle
aged men and women, and the only cross sectional study conducted on postmenopausal women
utilized a cycle ergometry test to measure VO 2max.3, 29 Both of the VO2max protocols reported a
higher VO2max measurement and was associated with lower CRP levels. It is important to note
that physical activity must be maintained though out life to maintain lower CRP levels and a
lower risk of developing CVD.10
Physical activity has been shown to decrease the risk of CVD in women, but intensity is
an important factor .37, 47 Lewis25 reported 80% lower risk for a cardiovascular risk and decreased
CPR level if moderate to vigorous activity was performed for 30 minutes most days of the week,
while Sesso47 reported that light activity, such as walking, can reduce the CVD risk by 33% but
the relationship was not significant enough to state that physical activity is associated to CVD.
Interestingly, a meta-analysis by Oguma 37 reported that walking 1 hour/week can decrease CVD
risk according to the dose-response relationship.
Table 4: Effects of C-Reactive Protein with Weight Loss through Physical Activity
Article
Problem/Question
Participants
Procedures
Studied
Reduction in CTo assess the effects
277 patients with
Diet modifications to
reactive protein
of 3-month formal
CHD (235 completed promote weight loss
through cardiac
phase II cardiac
cardiac rehab
and exercise
rehabilitation and
rehabilitation and
program while 42
intervention were
exercise training
exercise training
were the control
implemented 3 d/wk;
(Milani, 2004).
program on highgroup and did not
blood samples were
sensitivity CRP levels receive rehab).
taken 2-6 weeks
in patients with
after hospital
coronary heart
discharge and again
disease.
3-6 months
following baseline.

Findings
Therapeutic
lifestyles changes
through cardiac
rehabilitation can
promote significant
improvements in
cardiac risk factors;
favorable effects of
CRP through
rehabilitation were
independent of
weight loss.
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Article
Leisure time
physical activity and
reduced plasma
levels of obesity
related inflammatory
markers (Pischon,
2003).

Problem/Question
Studied
To investigate the
relationship between
physical activity and
the obesity related
inflammatory marker
C-reactive protein.

Participants

Procedures

Findings

405 healthy men and
454 healthy women.

Cross-sectional
study from 1986 and
1997; Blood samples
were requested
between 1993-1995;
diet was assessed
every 4 years;
physical activity was
determined from a
questionnaire in
1994.

Socioeconomic
information was
collected via phone,
physical
examinations and lab
measurements were
performed in a
mobile center, and
blood samples were
collected locally.
Cross sectional
study; self reported
height and weight
and questionnaire for
physical activity was
completed; blood
samples were
collected.

Frequent physical
activity is associated
with lower systemic
inflammation and
higher insulin
sensitivity; in
contrast to fat mass,
inflammation
markers explained
little regarding the
physical activity and
insulin sensitivity
relationship.
Low cardiorespiratory affects 1
out of 5 persons
aged 12-49 resulting
in higher BMI;
therefore, BMI is
inversely related to
fitness level.

Prevalence and
cardiovascular
disease correlates of
low cardiorespiratory fitness in
adolescents and
adults (Carnethon,
2005).

To describe the
prevalence of low
fitness in the US
population aged 1249 years and to relate
low fitness to CVD
risk factors.

Cohort study of
3,110 12-19 yr olds
and 2,205 20-49 yr
olds.

Association of
physical activity and
body mass index
with novel and
traditional
cardiovascular
biomarkers in
women (Mora,
2006).
Effect of weight loss
and lifestyle changes
on vascular
inflammatory
markers in obese
women (Esposito,
2003).

To examine the
association of
physical activity, BMI
alone and in
combination with
cardiovascular
markers.

27,158 apparently
healthy US women.

To determine the
effect of lifestyle
changes to reduce
body weight on
markers of systemic
vascular
inflammatory and
insulin resistance.
To determine whether
improvements in
insulin sensitivity
with weight loss are
mediated by changes
in inflammation in
obese,
postmenopausal
women.

120 premenopausal
obese women (20-46
years).

24 m. intervention;
Mediterranean 1300
kcal diet and
increased physical
activity

Reduction in weight
loss was associated
with reduction in
vascular
inflammatory
markers and insulin
resistance.

37 sedentary,
overweight/obese
postmenopausal
women.

6 m. diet & exercise
intervention;
baseline
measurements
including
anthropometric
measurements,
fasting blood profile,
and graded treadmill
test; weekly
meetings with a RD,
3 d/wk exercised on
treadmills or bikes.

Body weight,
percentage body fat,
fat mass, fat free
mass, and visceral
adipose tissue
decreased with
weight loss,
however VO2max did
not change after
weight loss.
Glucose utilization
and insulin
sensitivity were
inversely related to
CRP changes.

Reductions in
plasma cytokine
levels with weight
loss improve insulin
sensitivity in
overweight and
obese
postmenopausal
women (Ryan,
2004).

Lower levels of
physical activity and
higher levels of BMI
were independently
associated with
increased
inflammatory
markers.
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Article
Can exercise training
with weight loss
lower serum Creactive protein
levels? (Okita,
2004).

Problem/Question
Studied
To examined the
effects of exercise
training with weight
loss on CRP levels
and conventional
CVD risks.

Participants

Procedures

Findings

199 healthy Japanese
women (129
postmenopausal).

2 m intervention;
subjects did aerobic
exercise 2 d/wk (80
min dance and 30-60
min treadmill);
blood samples (after
12 hr fast),
anthropometric
measurements,
muscular strength
and CV endurance
were tested at
baseline and 2
months later.

Body weight
significantly
decreased and CRP
levels were lowered
after exercise
intervention;
adipose tissue is
likely a factor
modulating CRP
levels.

Lifestyles changes, especially physical activity, can promote significant improvements of
CVD risk factors, such as decreased CRP levels. Cross sectional and 3-month intervention
studies with men and women reported that independent of weight loss, with an increase in
physical activity there was a decrease in CRP levels.30, 40 Along with decreased inflammatory
markers, decreased weight, body fat percentage, adipose tissue, and BMI result from increased
physical activity.8,45 Cross sectional with men and women and 6-month intervention with
postmenopausal women concluded that there is an inverse relationship between BMI and physical
activity level. Intervention studies consisted of postmenopausal women exercising 3 days/week
running or cycling for 30-60 minutes at 60% VO2max or between 60-80% peak heart rate.38, 45
There was an inconsistency within the literature regarding the effect of decreased BMI has on
CRP level. According to Okita et al,38 CRP levels were affected by the decrease in adipose
tissue; however, Milani et al30 reported the decrease in CRP levels were independent of weight
loss or decrease in BMI.

Chapter III
Methodology
Participants
Thirty-one women responded to the initial request for study volunteers. Twenty-one
postmenopausal women who were recruited from the James Madison University and
Harrisonburg Rockingham County communities volunteered as participants for this study. The
subjects were reached through email flyers, e-mail, and by word of mouth. Persons who showed
interest in participating were screened to see if they met the minimum criteria for entrance into
the study. The criteria for inclusion included: Apparently healthy (no diagnoses of cardiovascular
disease), female, post-menopausal (no regular menstrual cycle in the past 12 months), and
previously sedentary (no regular exercise (<2 days per week) in the past 6 months). All study
protocols and procedures were approved by the Institutional Review Board.
Overview of Procedures
The protocol was designed to determine the independent effects of weight loss initiated through
dietary changes and fitness (VO2max) without weight loss on CRP levels in post menopausal
women. Some of the measurements were used for other studies and are not related to the research
question being investigated. Pre- and post testing measurements were completed during separate
four sessions.
First Session
During the first pre-test session all test procedures and protocols were explained to the
participants who completed an Informed Consent Form (Appendix I), Health Status
Questionnaire (Appendix II) and PAR-Q (Appendix III). In addition, all participants were given
a Dietary 24-hour Food Recall (Appendix IV) explained by a registered dietitian. The ACSM’s
Coronary Artery Disease Risk Factor Thresholds along with the ACSM Risk Stratification were
used to assess the risk for cardiovascular disease. Risk stratification was based upon age, family
history, smoking habits, blood lipid levels, CRP levels (non-traditional risk factor), fasted blood
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glucose values, resting blood pressure, body mass index, and physical activity habits. Other
questionnaires completed, but not used for the current study included: the International Physical
Activity Questionnaire (IPAQ) designed to assess the volume of physical activity that the
participant engaged in prior to enrolling in the study, the Pittsburgh Sleep Quality Index (PSQI)
to assess the sleep quality of the participants, the Epworth Sleepiness Scale (ESS) evaluated the
tendency to doze off during daytime activities, the U.S Department of Health and Human
Services Health Behavior Questionnaire to assess lifestyle behaviors, and the Health Related
Quality of Life questionnaire (HRQOL-4) assessed health related quality of life.
Second Session
The second session included a venous blood draw, measurement of resting blood pressure, and
body composition assessment via dual-energy x-ray absorptiometry (DEXA Hologic, Bedford,
Massachusetts). After an overnight fast, blood obtained from the anticubital vein and was stored
at -80oC until serum was analyzed for CRP. Serum CRP levels were determined using an
Enzyme Linked Immunoassay (ELISA) kit (BioCheck Inc, Foster City, California). Blood lipid
values (total cholesterol, HDL cholesterol, triglycerides) were measured and determined using
dry slide technology (Johnson and Johnson Vitro DT 6011, Rochester, New York). LDL
cholesterol values were obtained using the Friedewald equation. Blood lipid values were not
included for analysis in the current study. Height was measured to the nearest 0.25 cm and body
weight was measured to the nearest 0.25 pounds to calculate BMI (kg/m2). Also, waist
circumference was measured at least twice to the nearest centimeter using a tension-controlled
tape measure according to procedures as specified in the ACSM Guidelines for Exercise Testing
and Prescription (eighth edition, 2009).
Third Session
The third session included a graded walking test on a treadmill (Quinton Club Track 612, Bothell,
Washington) (Appendix V) to determine cardiovascular endurance (maximal oxygen
consumption VO2max). Oxygen consumption, heart rate, and rating of perceived exertion were
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monitored throughout the test. Metabolic measures were calculated using open circuit spirometry
via a computerized metabolic cart (Sensormedics Vmax 229, Yorba Linda, California). At the
end of the first stage, workload was increased by increasing the elevation (grade) on the treadmill
every three minutes. The protocol continued in the same manner for three minute stages until the
participant reached volitional fatigue, their age-predicted maximal heart rate, asks to stop, or
experiences adverse signs or symptoms (ACSM, 2010).
Fourth Session
The fourth pre-test session consisted of muscular strength, muscular endurance, and flexibility
measurement used for a larger project. Muscular strength of the upper and lower body was
measured by completing a 5 repetition maximum (RM) on the chest press and leg press machines
(Cybex, Medway, Massachusetts). Participants completed a number of submaximal repetitions as
a warm up. A weight that was within 50-70% of perceived capacity for 5 repetitions was
selected, and the participant completed 5 repetitions at this weight. If 5 repetitions were
successfully completed, weight increased following a 3 to 5 minute rest period and 5 more
repetitions were attempted. This protocol continued until the participant could no longer
complete 5 repetitions at a selected weight. Muscular endurance was measured by following
ACSM push-up and curl-up test procedures. For the push-up test, participants assumed the
modified “knee push-up” position, with legs together, lower leg in contact with the mat and toes
pointed, back straight and hands shoulder width apart. The participant performed as many
modified “knee push-ups” as possible by straightening the elbows and then lowering the body
until the chin touched the mat. For the curl-up test, participants assumed a supine position on a
mat with the knees at 90-degree angles. Arms were at the side with palms facing down and
fingers touching a piece of masking tape. A second piece of tape was placed 10 centimeters in
front of the first piece. A metronome was set to 50 beats per minute, and the participant
performed curl ups in time to the metronome, lifting the shoulder blades off the mat to touch the
second piece of tape. The number of curl-ups performed without pausing, or a maximum of 25,
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was recorded as the score. Muscular flexibility was assessed using the V-Sit and Reach test.
Participants sat without shoes with the soles of the feet flat against a sit-and-reach box
(flexometer) at the 26-centimeter mark. Participants slowly reached forward as far as possible,
keeping the legs straight and both hands overlapped, and holding this position for approximately
2 seconds. The most distant point reached with the fingertips was recorded.
Interventions
Weight Loss: Dietary Intervention (DI)
Participants were randomly assigned to a hypocaloric dietary intervention (DI) for 9 weeks.
Participants reported to the James Madison University Human Performance Laboratory once a
week for a body weight measurement. The study’s goal for DI participants was an 8-10% weight
loss from baseline weight. Assessment of dietary and beverage intake by 24-hour Food Recall
and dietary guidance administered by a registered dietician occurred pre-intervention, week six of
intervention, and post-intervention.
Maximal oxygen consumption (VO2max): Exercise Intervention (EXI)
Participants randomly assigned to an exercise intervention (EXI) reported to James Madison
University Crawford Fitness Center 3 days per week for 45-55 minute sessions. The study’s goal
for the EXI participants was to increase cardiovascular endurance from baseline VO 2max.
Cardiovascular training was initially set for each participant to train at 60% of VO2max and
gradually progress to training at 75-80% of max by week 9 of the intervention; participants had
the option of walking, cycling, elliptical, or rowing. Resistance training consisted of a circuit of
upper and lower body exercises designed to improve muscular strength and endurance.
Participants trained at an intensity of that allowed each individual to perform between 8-15
repetitions (60-70% of 1RM) per set. The regimen began with one set of each exercise and
progressed to 2 sets of each exercise by week 9 of the intervention. Resistance exercises were
performed on Cybex equipment (Cybex, Medway, Massachusetts). Upper body exercises
included chest press, bicep curl, triceps extension, and latissimus pull down. Lower body
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exercises will include leg extension, leg curl, leg press, and calf raises. Two additional resistance
exercises were added to increase muscular strength and endurance of the core. Exercise sessions
also gradually increased in time. Sessions started at 30 minutes and progressed to 60 minutes per
session (30 minutes performing cardiovascular exercise and 30 minutes of resistance exercise).
Statistical Analysis
Differences in CRP levels and dependent variables (weight, BMI, fat mass, body fat percent,
waist circumference, and VO2max) within the DI and EXI were compared by repeated measures
analysis of variance. Post-hoc paired t-tests were performed on variables that demonstrated
significance between interventions to determine significance in change (pre-post). Descriptive
statistics were calculated for each treatment and measurement. SPSS statistical software package
(SPSS, Somers, New York) was used for all data analysis.
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ABSTRACT
Background: Cardiovascular disease (CVD) risk factors that are intensified in postmenopausal
women include body fat, blood pressure, dyslipidemia, and high sensitivity C-reactive protein
(CRP) levels. CRP has been reported as an independent indicator of risk for cardiovascular
events. CRP is affected by multiple factors such as age, race, body mass index (BMI), and
physical activity level. The purpose of this study was to examine whether weight loss or exercise
without weight loss had an impact on CRP levels. Methods and Results: Twenty apparently
healthy postmenopausal women were randomly assigned to a diet intervention group (DI) or an
exercise intervention group (EXI) for a period of 9 weeks. DI participants reported once a week
for a body weight measurement and EXI participants were asked to attend three 45-60 minute
sessions per week (cardiovascular and resistance training exercises). There were no significant
differences effects of time or treatment on CRP levels (p=0.077). However, there was a
significant change (-4.45 kg) in body weight (p=0.000, p< 0.05) and (-1.1 kg) change in fat free
mass (p=0.041, p<0.05) in the DI group. Our study found that there was no significance in the
change in CRP within the DI or EXI group. Conclusions: Body weight, FFM, and waist
circumference all decreased significantly in the DI group; however, decreases in these variables
did not appear to precipitate significant changes in CRP. It is possible that a greater degree of
weight loss (over a longer duration) may be necessary to decrease CRP levels. There was no
significance between EXI and dependant variables, including CRP, also suggesting that greater
intensity or longer intervention duration may be necessary to affect dependant variables through
exercise.

Key Words: cardiovascular disease, diet, exercise.
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INTRODUCTION
Cardiovascular disease (CVD) is the major cause of death among the U.S. population.8, 16,
33

With aging, the risk of CVD proportionally increases; however, women are affected by CVD

10 years after men.25,33 Risk factors for CVD in women are smoking (leading cause),
hypertension, dyslipidemia, diabetes mellitus, obesity, sedentary lifestyle, and menopause.6, 25, 33,
44, 46

Increased abdominal adiposity, associated with obesity, is a risk factor for CVD in women;

the prevalence of obesity has increased over the past decade and currently one out of three
women is classified as obese. Obesity is a parallel factor to sedentary lifestyle, and studies have
shown that moderate physical activity reduces the risk of CVD by 50% in women. Schenck46
reported in 2009 that 30% of women are overweight and 27% are classified as obese, and the risk
for CVD in obese women increases 3-fold compared to lean women.20, 25, 33 Menopause decreases
the estrogen levels and increases testosterone levels in postmenopausal women negatively
affecting cardiovascular functions and metabolism resulting in an increase risk for CVD event,
such as dyslipidemia resulting from increased testosterone.25
In addition to the blood lipids, abnormal lipoprotein, C-reactive protein (CRP) and
interleukin-6 levels are known risk factors for CVD in women. 3, 13, 15, 39, 46 Inflammation markers
have been determined to have a significant role in the development of atherosclerosis and CVD,
but the relationship between the inflammation process and CVD is complex.4, 16, 22 In response to
tissue inflammation, CRP is stimulated by interleukin-6, interleukin-1, and tumor neurosis
factor.22 This response occurs when activated immune cells in the plaque produce inflammatory
cytokines, stimulating the production of substantial amounts of interleukin-6. Interleukin-6, in
response, stimulates the production of large amounts of acute-phase reactants (C-reactive protein,
serum amyloid A, and fibrinogen) in the liver. Plasma concentration of CRP can increase 100fold after acute inflammatory stimulus.5, 11, 42 According to Hansson,16 cytokines have important
biologic effects at all steps; however, their amplification at each step of the cascade makes the
measurement of downstream mediators such as CRP particularly useful for clinical diagnosis.
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CRP is an independent indicator of risk for stroke, peripheral vascular disease, and vascular death
among healthy men and women without any known vascular diseases and is a stronger predictor
for CV events compared to LDL-C levels. 5, 11, 42, 43 Currently practitioners consider CRP value of
less than 2 mg/L as healthy, and individuals who have CRP levels of 5mg/L or greater may be at
an increased risk for a cardiac event within six months.22, 26
CRP is affected by multiple factors such as age, race, body mass index (BMI), and
physical activity level.1, 3, 4, 9, 13, 14, 17, 18, 22, 28, 49, 52, 53 CRP levels have been shown to increase with
age; therefore, BMI and physical activity level have to counteract the natural rise in CPR levels.22,
28

CRP is highly correlated with BMI and several studies have reported a strong correlation

between total fat mass and visceral fat and CRP.17, 18, 23, 52 Heilbroon17 and Williams 53 have
reported that subjects with a BMI >30 kg/m2 had elevated CRP levels and CRP levels were 270%
higher in individuals in the top quintile of BMI compared to those in the bottom quintile. In
addition to BMI, a direct relationship between elevated CRP levels and abdominal fat distribution
via waist circumference measurement has been documented.17, 18, 52 A waist circumference
greater than 88 centimeters indicates higher BMI values and higher risk for CVD due to increased
visceral fat and increase in serum resistin. 18, 51 When comparing race, more black women are
considered obese and have higher CRP levels than white women. 23 Finally, CRP levels have
been shown to have an inverse relationship with physical activity level. 29 Increased physical
activity levels are related to decreased fat and lower BMI resulting in decreased CPR levels.1, 3, 14,
29, 49

It has been observed that the lowest CRP levels in individuals with the highest activity
levels.1,3,10,14 Physical activity is associated with a lower risk of subsequent CVD events;
however, physical activity in young adulthood was not a predictor of CVD risk several decades
later.10 Along with an inverse relationship between physical activity level and CRP, there is an
inverse association between intensity and/or frequency of exercise with CRP levels. CRP levels
decrease with more vigorous exercise or more frequent exercise.1, 3, 49 Multiple studies have
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shown that with weight loss and exercise, CRP levels decrease in proportion to weight loss.30, 38,
40, 45

Increased physical activity promotes decreased weight, body fat percentage, adipose tissue,

and BMI resulting in decreased CRP levels.45 Intervention studies consisting of aerobic activity 3
days/week through group exercise classes, treadmill, or cycling for 30-60 minutes at 60% VO2max
or between 60-80% peak heart rate resulted in a decrease in body weight, percentage body fat, fat
mass, fat free mass, visceral adipose tissue, and decrease in CRP levels, however VO 2max did not
change after weight loss during an exercise intervention.30, 38, 45
Research has shown that CRP decreases with weight loss through diet alone. The
majority of diet interventions reviewed consisted of a 1200 kcal/day diet for a period of 12 weeks
with obese women as the study population.10, 14, 49 The diet intervention protocols consisted of
1200 kcal/week. 35, 36, 50 Previous studies have solely investigated changes of CRP levels resulting
from weight loss through dietary alterations or weight loss through exercise. It is unknown if
weight loss or exercise status alone have an effect on CRP levels in sedentary, postmenopausal
women. The purpose of this study was to compare the effects of an exercise intervention versus a
dietary intervention on traditional (BMI, percent body fat, waist circumference, physical activity
level) and non-traditional (CRP) risk factors for cardiovascular disease in sedentary, post
menopausal women.

PARTICIPANTS AND METHODS
Participants
Thirty-one women responded to the initial request for study volunteers. Twenty-one
postmenopausal women who were recruited from the James Madison University and
Harrisonburg Rockingham County communities volunteered as participants for this study. The
subjects were reached through email flyers, e-mail, and by word of mouth. Persons who showed
interest in participating were screened to see if they met the minimum criteria for entrance into
the study. The criteria for inclusion included: Apparently healthy (no diagnoses of cardiovascular
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disease), female, post-menopausal (no regular menstrual cycle in the past 12 months), and
previously sedentary (no regular exercise (<2 days per week) in the past 6 months). All study
protocols and procedures were approved by the Institutional Review Board.
Overview of Procedures
The protocol was designed to determine the independent effects of weight loss initiated through
dietary changes and fitness (VO2max) without weight loss on CRP levels in post menopausal
women. Some of the measurements were used for other studies and are not related to the research
question being investigated. Pre- and post testing measurements were completed during separate
four sessions.
First Session
During the first pre-test session all test procedures and protocols were explained to the
participants who completed an Informed Consent Form (Appendix I), Health Status
Questionnaire (Appendix II) and PAR-Q (Appendix III). In addition, all participants were given
a Dietary 24-hour Food Recall (Appendix IV) explained by a registered dietitian. The ACSM’s
Coronary Artery Disease Risk Factor Thresholds along with the ACSM Risk Stratification were
used to assess the risk for cardiovascular disease. Risk stratification was based upon age, family
history, smoking habits, blood lipid levels, CRP levels (non-traditional risk factor), fasted blood
glucose values, resting blood pressure, body mass index, and physical activity habits. Other
questionnaires completed, but not used for the current study included: the International Physical
Activity Questionnaire (IPAQ) designed to assess the volume of physical activity that the
participant engaged in prior to enrolling in the study, the Pittsburgh Sleep Quality Index (PSQI)
to assess the sleep quality of the participants, the Epworth Sleepiness Scale (ESS) evaluated the
tendency to doze off during daytime activities, the U.S Department of Health and Human
Services Health Behavior Questionnaire to assess lifestyle behaviors, and the Health Related
Quality of Life questionnaire (HRQOL-4) assessed health related quality of life.

28
Second Session
The second session included a venous blood draw, measurement of resting blood pressure, and
body composition assessment via dual-energy x-ray absorptiometry (DEXA Hologic, Bedford,
Massachusetts). After an overnight fast, blood obtained from the anticubital vein and was stored
at -80oC until serum was analyzed for CRP. Serum CRP levels were determined using an
Enzyme Linked Immunoassay (ELISA) kit (BioCheck Inc, Foster City, California). Blood lipid
values (total cholesterol, HDL cholesterol, triglycerides) were measured and determined using
dry slide technology (Johnson and Johnson Vitro DT 6011, Rochester, New York). LDL
cholesterol values were obtained using the Friedewald equation. Blood lipid values were not
included for analysis in the current study. Height was measured to the nearest 0.25 cm and body
weight was measured to the nearest 0.25 pounds to calculate BMI (kg/m2). Also, waist
circumference was measured at least twice to the nearest centimeter using a tension-controlled
tape measure according to procedures as specified in the ACSM Guidelines for Exercise Testing
and Prescription (eighth edition, 2009).
Third Session
The third session included a graded walking test on a treadmill (Quinton Club Track 612, Bothell,
Washington) (Appendix V) to determine cardiovascular endurance (maximal oxygen
consumption VO2max). Oxygen consumption, heart rate, and rating of perceived exertion were
monitored throughout the test. Metabolic measures were calculated using open circuit spirometry
via a computerized metabolic cart (Sensormedics Vmax 229, Yorba Linda, California). At the
end of the first stage, workload was increased by increasing the elevation (grade) on the treadmill
every three minutes. The protocol continued in the same manner for three minute stages until the
participant reached volitional fatigue, their age-predicted maximal heart rate, asks to stop, or
experiences adverse signs or symptoms (ACSM, 2010).
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Fourth Session
The fourth pre-test session consisted of muscular strength, muscular endurance, and flexibility
measurement used for a larger project. Muscular strength of the upper and lower body was
measured by completing a 5 repetition maximum (RM) on the chest press and leg press machines
(Cybex, Medway, Massachusetts). Participants completed a number of submaximal repetitions as
a warm up. A weight that was within 50-70% of perceived capacity for 5 repetitions was
selected, and the participant completed 5 repetitions at this weight. If 5 repetitions were
successfully completed, weight increased following a 3 to 5 minute rest period and 5 more
repetitions were attempted. This protocol continued until the participant could no longer
complete 5 repetitions at a selected weight. Muscular endurance was measured by following
ACSM push-up and curl-up test procedures. For the push-up test, participants assumed the
modified “knee push-up” position, with legs together, lower leg in contact with the mat and toes
pointed, back straight and hands shoulder width apart. The participant performed as many
modified “knee push-ups” as possible by straightening the elbows and then lowering the body
until the chin touched the mat. For the curl-up test, participants assumed a supine position on a
mat with the knees at 90-degree angles. Arms were at the side with palms facing down and
fingers touching a piece of masking tape. A second piece of tape was placed 10 centimeters in
front of the first piece. A metronome was set to 50 beats per minute, and the participant
performed curl ups in time to the metronome, lifting the shoulder blades off the mat to touch the
second piece of tape. The number of curl-ups performed without pausing, or a maximum of 25,
was recorded as the score. Muscular flexibility was assessed using the V-Sit and Reach test.
Participants sat without shoes with the soles of the feet flat against a sit-and-reach box
(flexometer) at the 26-centimeter mark. Participants slowly reached forward as far as possible,
keeping the legs straight and both hands overlapped, and holding this position for approximately
2 seconds. The most distant point reached with the fingertips was recorded.
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Interventions
Weight Loss: Dietary Intervention (DI)
Participants were randomly assigned to a hypocaloric dietary intervention (DI) for 9 weeks.
Participants reported to the James Madison University Human Performance Laboratory once a
week for a body weight measurement. The study’s goal for DI participants was an 8-10% weight
loss from baseline weight. Assessment of dietary and beverage intake by 24-hour Food Recall
and dietary guidance administered by a registered dietician occurred pre-intervention, week six of
intervention, and post-intervention.
Maximal oxygen consumption (VO2max): Exercise Intervention (EXI)
Participants randomly assigned to an exercise intervention (EXI) reported to James Madison
University Crawford Fitness Center 3 days per week for 45-55 minute sessions. The study’s goal
for the EXI participants was to increase cardiovascular endurance from baseline VO 2max.
Cardiovascular training was initially set for each participant to train at 60% of VO2max and
gradually progress to training at 75-80% of max by week 9 of the intervention; participants had
the option of walking, cycling, elliptical, or rowing. Resistance training consisted of a circuit of
upper and lower body exercises designed to improve muscular strength and endurance.
Participants trained at an intensity of that allowed each individual to perform between 8-15
repetitions (60-70% of 1RM) per set. The regimen began with one set of each exercise and
progressed to 2 sets of each exercise by week 9 of the intervention. Resistance exercises were
performed on Cybex equipment (Cybex, Medway, Massachusetts). Upper body exercises
included chest press, bicep curl, triceps extension, and latissimus pull down. Lower body
exercises will include leg extension, leg curl, leg press, and calf raises. Two additional resistance
exercises were added to increase muscular strength and endurance of the core. Exercise sessions
also gradually increased in time. Sessions started at 30 minutes and progressed to 60 minutes per
session (30 minutes performing cardiovascular exercise and 30 minutes of resistance exercise).
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Statistical Analysis
Differences in CRP levels and dependent variables (weight, BMI, fat mass, body fat percent,
waist circumference, and VO2max) within the DI and EXI were compared by repeated measures
analysis of variance. Post-hoc paired t-tests were performed on variables that demonstrated
significance between interventions to determine significance in change (pre-post). Descriptive
statistics were calculated for each treatment and measurement. SPSS statistical software package
(SPSS, Somers, New York) was used for all data analysis.

RESULTS
Thirty-one women responded to the study’s advertisement and twenty-one women agreed
to be participants in the study and completed pre-testing. Twenty sedentary, postmenopausal
women (48-67 years; DI group 56 ± 4.35 and EXI group 59.8 ± 5.88 years) completed the study.
One woman completed pre-testing but discontinued the study prior to the intervention phase. Ten
women were randomly assigned to the diet intervention group and 10 women were randomly
assigned to the exercise intervention group. Table 5 illustrates the change in dependant variables
pre and post intervention.
Table 5: Differences in pre-measurements and post-measurements.
Measurement
DI Pre
DI Post
DI ∆
CRP (mg/L)
3.69 ± 2.01
2.83 ± 2.84
-0.86 ± 1.09
Weight (kg)*
83.4 ± 17.9
79.7 ± 17.6
-4.4 ± 2.3
Fat Free Mass (kg)*
46.6 ± 6.4
45.5 ± 6.3
-1.0 ± 1.7
BF %
42.7 ± 5.1
41.0 ± 5.8
-1.7 ± 1.5
BMI (kg/m2)*
31.7 ± 6.6
30.1 ± 6.6
-1.6 ± 0.8
WC (cm)*
89.3 ± 11.4
86.1 ± 11.9
-3.2 ± 2.5
VO2max (L/min)
2.02 ± 0.30
1.99 ± 0.20
-0.02 ± 0.18
VO2max (mL/kg/min) 24.93 ± 5.87 26.19 ± 6.65
1.26 ± 2.17
All values reported as mean ± standard deviation.
*p<0.05

EXI Pre
2.27 ± 1.97
66.9 ± 10.3
40.3 ± 4.2
38.1 ± 6.8
26.1 ± 4.4
81.1 ± 7.6
1.81 ± 0.23
27.77 ± 4.89

EXI Post
3.07 ± 2.57
66.5 ± 10.8
40.5 ± 4.7
37.4 ± 7.0
26.2 ± 4.7
81.1 ± 8.6
1.86 ± 0.26
28.59 ± 5.30

There was no significant effect of time (p=0.971) or treatment (p=0.717) on CRP level.
There were statistical differences in baseline weight (p=0.019, p<0.05) and baseline FFM
(p=0.018, p<0.05) between the DI and EXI groups.

EXI ∆
0.79 ± 1.09
-0.3 ± 1.0
0.1 ± 0.5
-0.6 ± 0.8
0.3 ± 0.8
-0.0 ± 1.9
0.04 ± 0.12
0.82 ± 1.94
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Figure 2 provides pre and post measurements of weight and FFM variables. There was
significant time x treatment effect for both weight and FFM (p<0.05). The DI group experienced
a significant decrease in weight (-4.4 ± 2.3 kg). Although there was a time x treatment effect,
FFM did not change from pre- to post-testing for either the DI o EXI group (p=0.076 and
p=0.369, respectively) after performing paired t-tests. Figures 3 and 4 provide pre- and postmeasurements of BMI and waist circumference variables. There was a time x treatment effect for
BMI (p=0.000) and waist circumference (p=0.005). The change in BMI was -1.6 ± 0.8 kg/m2
(p=0.000) and the change in waist circumference was -3.2 ± 2.5 cm (p=0.003) within the DI
group. There was no difference in BMI or waist circumference in the EXI group. No difference
in body fat percentage (p=0.072) was found within groups because the objective of the EXI group
was to maintain weight; these aforementioned findings were expected.
There was no difference (p<0.05) in VO2max (mL/kg/min) in either of the intervention
groups. The objective of the DI group was to maintain fitness level; therefore in the lack of
change in VO2max was expected. The participants in the EXI group were asked to report 3 days
per week (27 sessions total) to complete a cardiovascular and resistance training circuit;
participants attended 24.6 ± 2.59 sessions during the intervention phase. Unfortunately, the aim
of the EXI group was to increase fitness and this goal was not achieved.
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Figure 1: Changes in CRP pre and post intervention.
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Figure 2: Pre and post measurements of body weight and fat free mass.
* p < 0.05

34

35
30

BMI kg/m2

25
20
15
10
5
0
Pre

Post *

Pre

DI *

Post
EXI

Waist Circumference (cm)

Figure 3: Pre and post measurements of body mass index.
* p < 0.05
94
92
90
88
86
84
82
80
78
76
74
72
Pre

Post *
DI *

Pre

Post
EXI

Figure 4: Pre and post measurements of waist circumference.
* p < 0.05

DISCUSSION
The purpose of this study was to compare the effects of an exercise intervention versus a
dietary intervention on traditional (BMI, waist circumference) and a non-traditional (CRP) risk
factor for cardiovascular disease in sedentary, postmenopausal women. Previous research has
established that CRP is a predictor for cardiovascular disease (CVD) in postmenopausal women. 4,
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25, 41, 44, 53

In addition, obesity has been determined to be a risk factor for increased risk for CVD

and potentially precipitating elevated CRP.13, 20, 54 Previous studies have reported that body
weights between 92-130 kg and/or a BMI between 25-46 kg/m2 were associated with CRP levels
above 3 mg/L.12, 18, 19, 23, 32, 39, 50, 51, 54 Individuals with a CRP level less than 2 mg/L are classified
as healthy, above 3 mg/L are considered at high risk for cardiovascular events, and above 5 mg/L
may be at an increased risk for a cardiac event within six months. 22, 26 Our study found that there
was no change in CRP with either intervention.
Even though CRP levels did not significantly change, there was a significant difference in
body weight and fat free mass in the DI group. It is possible that the participants’ baseline CRP
levels were classified as “at moderate risk” and that the weight loss was not great enough to elicit
a significant decrease in CRP levels. It has been reported that with a greater reduction in weight
loss there is a greater reduction in CRP level; Heilbronn17, 18 reported a 26% decrease in CRP
level with a 7.9 kg decrease after 12 weeks and Tchernof 50 stated a 32% decrease in CRP with a
weight loss of 15.6 kg after a 14 week intervention. Thus a greater degree of weight loss (over a
longer duration) may be necessary to decrease CRP levels. The BMI of participants in the DI
group were classified as obese class I, but CRP levels were not classified as “at risk”. Therefore,
an elevated BMI may be needed to observe a greater change in CRP levels. Nicklas34 reported
that there was a significant difference in CRP among the diet-induced weight loss group;
however, the baseline mean BMI was 34 kg/m2 and mean CRP was 6.0 g/mL. The current
study’s baseline measurements of body weight, BMI, and CRP were lower than participants in the
Nicklas34 study.
The relationship between physical activity and CRP is not well defined. Previous studies
investigating physical activity level and CRP have been primarily cross-sectional studies and the
consensus appears to be that higher physical activity level are associated with a lower BMIs
which results in lower CRP level.1, 2, 3,29, 47 To our knowledge there are no previous studies that
have reported that an increase in physical activity levels of individuals with elevated BMIs results
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in lower CRP levels, without concomitant changes in body weight or body fat. The investigators
have not been able to distinguish the independent effects of body weight (body fat) or fitness on
CRP. In the current study, physical activity only had minimal effects on the dependant
measurement of body fat percentage and fat free mass due to maintenance of body weight.
Decreases in body fat percentage and increases in fat free mass from weight loss through exercise
are generally associated with decreases in CRP levels.8,39 Past research regarding weight loss
through exercise has concluded that there is an inverse relationship with between physical activity
and BMI.8, 31, 45 Currently, there is controversy in the literature concerning the effect that weight
loss [decrease in adipose tissue] due to physical activity has on CRP level. Okita and colleagues 38
showed that CRP levels are affected by the decrease in adipose tissue from weight loss due to
physical activity, while other studies reported that independent of weight loss, with an increase in
physical activity there was a decrease in CRP levels.30, 40 The findings of the current study are
unique in that the exercise intervention was designed to increase fitness without weight loss in an
attempt to determine the independent effect of fitness on CRP levels. The exercise program was
not effective in increasing the participants VO2max. There were varied adaptations to the exercise
intervention. According to ACSM, a VO2max value of 28.7 mL/kg/min is classified as “fair” for
women between 50-60 years old. Out of the 10 women in the EXI group, 5 were classified below
fair (poor) and 5 were classified as fair, good, or excellent pre-intervention. Post-intervention, 6
women increased their VO2max from the EXI group. VO2max did not change in the DI group
regardless of the significant change in body weight; however, the objective of the DI group was
to lose weight and not increase fitness. The majority of earlier investigations that have examined
the relationship between physical activity and CRP have reported that low cardiorespiratory
fitness is associated with elevated CRP levels. 1, 2, 3,29, 47 The current study’s findings can be
compared to the findings in the Nicklas34 study in which participants were assigned to a 3 month
exercise intervention that consisted of cardiovascular endurance (50-75% of heart rate reserve)
and resistance training regimen for 3 days per week for 45 minutes. The authors of previously
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published studies have reported that there was no significant differences in CRP levels after an
exercise intervention.34 In attempting to explain the lack on change in the CRP level in the EXI
group, it may be a function of the low baseline values we measured in the study population prior
to the intervention. The CRP levels measured in the current study population were not classified
as “at risk”. Also, it may be possible that the intensity or duration of the exercise protocol was
not enough to elicit change in VO2max and CRP, or the modified treadmill protocol did not
effectively measure VO2max in this population of sedentary, postmenopausal women considering
their chief complaint of being uncomfortable during the test. Many participants stated they had a
dry mouth from the mouthpiece; this uncomfortable (or unfamiliar) sensation may have made the
participants stop the treadmill test prior to reaching a maximal effort. From this inconsistent
information, it can be stated a physical activity intervention without weight loss has an
inconclusive result on CRP levels without an adequate overload to elicit a significant increase in
VO2max.
Additional variables that were measured included BMI, body fat percentage, fat free
mass, and waist circumference. Previous studies concluded that a lower BMI is correlated with
lower CRP levels.18, 19, 32, 34, 50 Studies that examined weight loss through physical activity have
concluded that a 2-5 kg/m2 decrease in BMI, a 2-3% decrease in body fat percentage, a 1-3 kg
decrease in fat free mass, and 3-4% decrease in waist circumference were associated with a
decrease in CRP level.19, 45, 50, 52, 55 With the significant changes in BMI (decrease 1.7 ± 0.8
kg/m2) and waist circumference (decrease 3.2 ± 2.5 cm) in the DI, it was not a great enough
change to elicit a significant difference in CRP level. Since the participants had an “at risk” BMI
but not an “at risk” waist circumference or CRP level, it is possible that along with a BMI over 30
kg/m2, waist circumference should be greater than 88 cm and CRP levels need to be above 3
mg/L to observe a significant change.
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Limitations
The findings presented above should be interpreted with caution in view of the limitations of the
current study. A greater number of participants may have resulted in the observance of larger
differences in dependant measures between the two intervention groups. Another limitation was
the differences in the baseline measurements between the DI and EXI groups. Although all
participants were categorized as sedentary their BMI values ranged from healthy to obese. Also,
participants were volunteers that did not smoke and may have had a physical activity history prior
to the past 12 months; the pre-intervention profiles may not have permitted for a statistical
difference in CRP. Perhaps more importantly, the sequence of baseline and post-testing sessions
could have influenced CRP levels; some participants performed the VO2max or muscular fitness
tests less than 24 hours prior to the fasted blood draw. By performing exercise within 48 hours of
the blood draw this may have a negatively influenced the CRP levels. Finally, the compliance of
the DI participants with the initial weight loss goal of 8-10% from baseline weight was a
limitation; of the ten participant in the DI group, two women succeeded in achieving this goal,
while four other women achieved a weight loss between 5-6%.
Conclusion
Our study found that there was no significance in the change in CRP within the DI or EXI group.
The objective of decreasing weight was achieved because there was a significant difference in
body weight, fat free mass, BMI, and waist circumference within the DI group. These differences
were not great enough to have a significant difference in CRP level though. The objective of
increasing VO2max was not achieved within the EXI group. More research is needed to determine
if an increase in fitness level without weight loss has an impact on CRP levels.
Recommendations for Future
The first recommendation for future studies would be to recruit a greater number of participants
to form larger intervention groups and/or have a control group. The second recommendation
would be to have inclusion criteria in which participants are within overweight/obese category for
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BMI and are at poor to very poor levels of cardiovascular endurance (VO 2max). Finally, a physical
activity intervention study with a control group will enable an investigation of CRP levels with
increased physical activity level with weight maintenance will clarify the relationship.

Chapter V
Summary
C-reactive protein is an inflammatory marker that is an independent indicator of risk for
stroke, cardiovascular disease, and vascular death among postmenopausal women without any
known vascular diseases and may be a stronger predictor for CV events compared to LDL-C
levels.5, 11, 42, 43 Risk factors for CRP in women are age, smoking (leading cause), hypertension,
dyslipidemia, obesity, sedentary lifestyle, and menopause. 6, 25, 33, 44, 46 CRP levels have been
shown to increase with age; therefore, controlling BMI and physical activity level may help to
minimize the age dependent rise in CPR levels.22, 28 CRP is highly correlated with BMI; and
several studies have reported a strong correlation between total fat mass and visceral fat and
CRP.17, 18, 23, 52 Increased abdominal adiposity, associated with obesity, is a risk factor for CVD in
women; the prevalence of obesity has increased over the past decade and currently one out of
three women is classified as obese. Obesity is a parallel factor to sedentary lifestyle, and studies
have shown that moderate physical activity reduces the risk of CVD by 50% in women.
Schenck46 reported in 2009 that 30% of women are overweight and 27% are classified as obese,
and the risk for CVD in obese women increases 3-fold compared to lean women. 20, 25, 33
Menopause decreases the estrogen levels and increases testosterone levels in postmenopausal
women negatively affecting cardiovascular functions and metabolism resulting in an increase risk
for CVD event, such as dyslipidemia resulting from increased testosterone. Currently
practitioners consider CRP value of less than 2 mg/L as healthy, and individuals who have CRP
levels of 5mg/L or greater may be at an increased risk for a cardiac event within six months. 22, 26
Studies have been conducted on the obese, postmenopausal population and older men and
women to determine if weight loss through diet, physical activity, and/or physical activity with
weight loss affects CRP levels. Lifestyles changes, especially physical activity and diet, can
promote significant improvements of CVD risk factors, such as decreased CRP levels. Weight
loss through low calorie diet has been shown to reduce CRP levels in obese, postmenopausal

41
women since the in CRP levels is primarily associated with loss in fat mass during weight loss.50
There is fairly consistent evidence that physical activity is associated with decrease in CRP levels
and lower risk of CVD. There is an inverse relationship between activity level and CVD risk and
CRP level; as activity levels increase, CRP levels decrease.3, 10, 49 Also, CRP levels decrease with
more vigorous exercise or more frequent exercise. 1, 3, 49 Along with decreased inflammatory
markers, decreased weight, body fat percentage, adipose tissue, and BMI result from increased
physical activity.8, 45 Previous studies have solely investigated changes of CRP levels resulting
from weight loss through dietary alterations or weight loss through exercise. It is unknown if
weight loss or exercise status alone have an effect on CRP levels in sedentary, postmenopausal
women. The purpose of this study was to compare the effects of an exercise intervention versus a
dietary intervention on traditional (BMI, percent body fat, waist circumference, physical activity
level) and non-traditional (CRP) risk factors for cardiovascular disease in sedentary, post
menopausal women.
Thirty-one women responded to the initial request for study volunteers. Twenty-one
postmenopausal women who were recruited from the James Madison University and
Harrisonburg Rockingham County communities volunteered as participants for this study.
Persons who showed interest in participating were screened to see if they met the minimum
criteria for entrance into the study. The criteria for inclusion included: Apparently healthy (no
diagnoses of cardiovascular disease), female, post-menopausal (no regular menstrual cycle in the
past 12 months), and previously sedentary (no regular exercise (<2 days per week) in the past 6
months). Participation in the study was entirely voluntary and withdrawal at anytime was allowed
without any consequences. All study protocols and procedures were approved by the Institutional
Review Board. Pre and post testing measurements were completed during separate four sessions.
During the first pre-test session all test procedures and protocols were explained to the
participants who completed an Informed Consent Form, Health Status Questionnaire, and PARQ.
In addition, all participants were given a Dietary 24-hour Food Recall supervised by a registered
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dietitian. After an overnight fast, venous blood draw, measurement of resting blood pressure, and
body composition assessment via dual-energy x-ray absorptiometry. Blood obtained from the
anticubital vein was analyzed for CRP. The third session included a graded walking test on a
treadmill to determine cardiovascular endurance (maximal oxygen consumption VO 2max).
Oxygen consumption, heart rate and rating, of perceived exertion (RPE) were monitored
throughout the test. The fourth pre-test session consisted of muscular strength, muscular
endurance, and flexibility measurement used for a larger project.
The protocol in this study was designed to determine the independent effects of weight
loss initiated through dietary changes and fitness (VO 2max) without weight loss on CRP levels in
postmenopausal women. Participants were randomly assigned to a diet intervention (DI) or
exercise intervention (EXI) group. The objective of the DI was to produce an 8-10% weight loss
during the 9 week intervention through a 1,200 kcal/day diet. Participants reported once a week
for a body weight measurement, and assessment of dietary and beverage intake by 24-hour Food
Recall and dietary guidance occurred pre-intervention, week six of intervention, and postintervention. The objective of the EXI group was to increase cardiovascular fitness. Participants
in the EXI group were asked to report 3 days per week for 45-55 minute sessions. Cardiovascular
training was initially set for each participant to train at 60% of VO 2max and gradually progress to
training at 75-80% of max by week 9 of the intervention. Resistance training consisted of a
circuit of upper and lower body exercises designed to improve muscular strength and endurance.
Participants trained at an intensity of that allowed each individual to perform between 8-15
repetitions (60-70% of 1RM) per set. Sessions started at 30 minutes and progressed to 60
minutes per session.
There was no significant effect of time (p=0.971) or treatment (p=0.717) on CRP level.
There were statistical differences in baseline weight (p=0.019, p<0.05) and baseline FFM
(p=0.018, p<0.05) between the DI and EXI groups.
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There was significant difference with weight within (p=0.000) and FFM (p=0.04) and
between (p=0.031 and p=0.03) groups following the intervention. The DI group experienced
significant difference in change (∆) in weight -4.4 ± 2.3 kg (p=0.000). Although significance was
found in FFM within groups, no significance was found in the DI o EXI group (p=0.076 and
p=0.369, respectively) after performing a paired t-test. Figure 2 provides pre and post
measurements of weight and FFM variables. There was significant difference in BMI (p=0.000)
and waist circumference (p=0.005), but there was not a difference between interventions
(p=0.090) and (p=0.161), respectively. The change in BMI was -1.6 ± 0.8 kg/m2 (p=0.000) and
the change in waist circumference was -3.2 ± 2.5 cm (p=0.003) within the DI group. There was
no difference in BMI or waist circumference in the EXI group. Figures 3 and 4 provide pre and
post measurements of BMI and waist circumference variables. No difference in body fat
percentage (p=0.072) was found within groups. The objective of the EXI group was to maintain
weight; therefore, having no significance in body weight, BMI, or waist circumference is a
positive result.
Regarding fitness level, there was no difference in VO2max (mL/kg/min) within (p=0.639)
or between (p=0.312) intervention groups. The objective of the DI group was to maintain fitness
level; therefore no significant difference in VO2max is a positive result. Unfortunately, the aim of
the EXI group was to increase fitness and this goal was not achieved.
Even though significance was not found in CRP levels, there was a significant difference
in body weight and fat free mass in the DI group. It is possible that the participants’ baseline
CRP levels were classified as “at moderate risk” and that the weight loss was not great enough to
elicit a significant decrease in CRP levels. It has been reported that with a greater reduction in
weight loss there is a greater reduction in CRP level; Heilbronn17, 18 reported a 26% decrease in
CRP level with a 7.9 kg decrease after 12 weeks and Tchernof 50 stated a 32% decrease in CRP
with a weight loss of 15.6 kg after a 14 week intervention. Thus a greater degree of weight loss
(over a longer duration) may be necessary to decrease CRP levels. The BMI of participants in the
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DI group were classified as obese class I, but CRP levels were not classified as “at risk”.
Therefore, an elevated BMI may be needed to observe a greater change in CRP levels. The
current study’s baseline measurements of body weight, BMI, and CRP were lower than
participants in the Nicklas34 study. Nicklas34 reported that there was a significant difference in
CRP among the diet-induced weight loss group; however, the baseline mean BMI was 34 kg/m2
and mean CRP was 6.0 g/mL.
To our knowledge there are no previous studies that have reported that an increase in
physical activity levels of individuals with elevated BMIs results in lower CRP levels, without
concomitant changed in body weight or body fat. In the current study, physical activity did not
elicit a significant change in body fat percentage and fat free mass due to maintenance of body
weight. Decreases in body fat percentage and increases in fat free mass from weight loss through
exercise are generally associated with decreases in CRP levels. 8,39 The majority of previously
published studies that have investigated the relationship between physical activity and CRP have
reported that low cardiorespiratory fitness is associated with elevated CRP levels. 1, 2, 3,29, 47 The
current study’s findings can be compared to the findings in the Nicklas 34 study in which
participants were assigned to a 3 month exercise intervention that consisted of cardiovascular
endurance (50-75% of heart rate reserve) and resistance training regimen for 3 days per week for
45 minutes.
Our study found that there was no significance in the change in CRP within the DI or
EXI group. The objective of decreasing weight was achieved because there was a significant
difference in body weight, fat free mass, BMI, and waist circumference within the DI group.
However, these changes were not great enough to precipitate a significant difference in CRP,
which may be related to the initial low levels demonstrated in the study population. The
objective of increasing VO2max was not achieved within the EXI group and thus it is not surprising
that CRP did not change in addition to the fact that again the levels in the group were not
considered “at risk” or elevated. More research, through intervention studies, is needed to
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determine if there is an impact on CRP levels with an increase in fitness level without weight
loss.
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Appendix I
James Madison University
Departments of Kinesiology and Health Sciences
Consent for Investigative Procedure
(Informed Consent)
You are being asked to participate in a research study Women Inflammation Atherosclerosis and
Thrombosis (WAIAT) conducted by Drs. Judith A. Flohr, Jeremy Akers, Nicholas Luden, R. Theresa
Prodoehl and Christopher J. Womack from the Departments of Kinesiology and Health Sciences at James
Madison University. The purpose of this study is to determine the effects of diet induced weight loss and
exercise on traditional (blood pressure, blood lipids, BMI, blood glucose) and nontraditional risk factors (markers
of chronic inflammation hsCRP, IL-6, fibrinolysis profile (blood clotting potential), endothelial (lining/wall of
blood vessel function) function, and sleep quality) for cardiovascular disease (CVD) by using a randomized
controlled intervention trial in post menopausal women.
Research Procedures:
The study will consist of various supervised lab tests and questionnaires to measure the physical fitness,
health status, lifestyle behaviors, body composition, blood lipids and blood glucose, and risk for
cardiovascular disease in women.

Note: In the event you discover that any of the following information is not clear, please ask one
of the investigators to explain immediately.
In this study I understand I will be randomly assigned to one of the following intervention groups
Exercise Intervention (Training Protocol) Participants in this group will follow the program described
below
Frequency- Three (3-5) days per week, 45-55 minutes/session (Participants will be asked to
complete 3 to5 supervised sessions per week.
Intensity- Cardiovascular training will initially be set so that each participant is training at 60% of
her VO2max (maximal oxygen consumption) and gradually progress to training at 75-80% of max
by week 10 of the intervention. Resistance training- participants will perform a circuit of upper
and lower body exercises designed to improve muscular strength and endurance. Participants will
train at an intensity of that allows each individual to perform between 8-15 repetitions (60-70% of
1 Repetition Maximum (1RM) per set. The program will start with one set of each exercise and
progress to 2 sets of each exercise by week 10 of the intervention.
Time- Exercise sessions will start at 30 minutes and progress so that by week 10 of the
intervention each participant is spending approximately 20 minutes performing cardiovascular
exercise and 20 minutes of resistance exercise during each exercise session for a total of 40
minutes per session.
Type-Cardiovascular- Participants will have the option of walking, cycling, elliptical or rowing as
modes of cardiovascular training. Resistance exercises will be performed on selectorized
equipment. Upper body exercises will include chest press, bicep curl, triceps extension and lat
pull down. Lower body exercises will include leg extension, leg curl, leg press and calf raises.
Two additional resistance exercises will be added to increase muscular strength and endurance of
the core (i.e. abdomen and back).
Maintenance of weight- Participants in the EXI group will be asked to maintain baseline body
weight. Dietary 24-hr Food Recalls will be given to assess dietary and beverage intake.
Dietary Intervention Participants in this group will be asked to come to the Human Performance Laboratory
(Godwin Hall 209) once a week for a body weight measure, assessment of dietary and beverage
intake by 24-hr Food Intake Recall, and dietary guidance.
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In this study I understand the following measurements and tests will be taken:
Blood Pressure. Blood pressure measurements will be taken using a sphygmomanometer and stethoscope.
A blood pressure cuff will be placed over the brachial artery of the right arm, slightly above the elbow.
Blood Draws: A blood sample (10 milliliters, 2 teaspoons) will be obtained from each participant via
venapuncture of the antecubital vein during the test sessions #2 and #5. The following procedures will be
followed to minimize the transfer of blood-borne pathogens: investigators will wear latex gloves at all
times during blood sampling and testing. For each venous blood draw, the following measurements will be
taken: Blood lipids (total cholesterol (TCHOL), low density lipoprotein cholesterol (LDL-C) high density
lipoprotein cholesterol (HDL-C), triglycerides (TRIG), Hematocrit (packed cell volume), Hemoglobin
(Hb), markers of inflammation (High sensitivity C-Reactive Protein (hsCRP),Interleukin 6 (IL-6)), Blood
clotting factors (Tissue plasminogen activator (tPA) and plasminogen activator inhibitor (PAI),
vonWillenbrand factor) and blood glucose.
Health Status Health status will be determined via questionnaires and ACSM’s Risk Stratification for
Cardiovascular Disease Risk (ACSM, 2010). Assessment of a woman’s risk for cardiovascular disease will
be made using the ACSM’s Coronary Artery Disease Risk Factor Thresholds along with the ACSM Risk
Stratification. Risk stratification is based upon age, family history, smoking habits, blood lipid levels, and
fasted blood glucose values, resting blood pressure, body mass index and physical activity habits.
Health Related Quality of Life (HRQOL-4) –Health related quality of life status will be assessed using a
4 item questionnaire developed by the Centers for Disease Prevention and Control. The CDC’s HRQOL-4,
also referred to as the Healthy Days Core Module, will assess when the participant has felt that her physical
or mental health was not good in the previous 30 days
Physical Fitness – A series of physical fitness tests will be administered. The components of fitness to be
measured include cardiovascular endurance, muscular strength and endurance, and muscular flexibility.
a. Cardiovascular endurance. Cardiovascular endurance will be assessed through a walking test
performed on a treadmill. Oxygen consumption, blood pressure, heart rate and rating of perceived exertion
(RPE) will be monitored throughout the test. The workload will be increased gradually by raising the
elevation (grade) on the treadmill every three minutes. The test will continue in the same manner every
three minutes until the participant reaches volitional (voluntary) fatigue, their age-predicted maximal heart
rate or asks to stop.
b. Muscular strength. Upper body strength will be assessed using the chest press machine. You
will be asked to perform five repetitions on the chest press; the weight will be increased until you can no
longer complete five repetitions or at the point you wish to stop the test. Lower body strength will be
assessed using the leg press machine and will follow the same steps and the bench press test. A minimal
level of discomfort is associated with the completion of the muscular strength tests due to muscle soreness,
which may be felt 24-72 hours after the completion of the test.
c. Muscular endurance. Muscular endurance will be measured by following ACSM (2010) pushup and curl-up test procedures. For the push-up test, participants assume the modified “knee push-up”
position, with legs together, lower leg in contact with the mat and toes pointed, back straight and hands
shoulder width apart. The participant performs as many modified “knee push-ups” as possible by
straightening the elbows and then lowering the body until the chin touches the mat. The maximal number
of push-ups performed correctly and without rest recorded as the score (ACSM, 2010). For the curl-up test,
participants will assume a supine (face up) position on a mat with the knees at 90-degree angles. Arms will
be at the side with palms facing down and fingers touching a piece of masking tape. A second piece of tape
is placed 10 centimeters in front of the first piece. A metronome is set to 50 beats per minute, and the
participant does curl ups in time to the metronome, lifting the shoulder blades off the mat to touch the
second piece of tape. The number of curl-ups performed without pausing, or a maximum or 25, is recorded
as the score (ACSM 2010).
d. Muscular flexibility. Muscular flexibility will be assessed using the V-Sit and Reach test.
Participants will sit without shoes with the soles of the feet flat against a sit-and-reach box (flexometer) at
the 26-centimeter mark. Participants will slowly reach forward as far as possible, keeping the legs straight
and both hands overlapped, and holding this position for approximately 2 seconds.
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Lifestyle Behaviors
a. Exercise Behavior – The volume of physical activity that the participant engaged in prior to
enrolling in the study will be estimated using the International Physical Activity Questionnaire (IPAQ). The
questionnaire consists of 5 activity domains, asked independently, in which the participant reports about the
time spend being physically active in the last 7 days.
b. Dietary Behavior –Dietary 24-hr Food Recalls will be taken from study participants to assess
dietary intake including beverage consumption. Participants in both groups will be given proper dietary
interventions by a Registered Dietitian. Two-dimensional food diagrams will be provided to assist
participants in portion size determination. All food and beverage records will be reviewed for accuracy and
completeness and analyzed using the NutritionistPro nutrition analysis software.
c. Sleep Quality –Participants will complete the Pittsburgh Sleep Quality Index (PSQI) which has
19 self-rated questions about sleep over the past month
d. Daytime Sleepiness-Participants will complete the Epworth Sleepiness Scale (ESS) which has 8
self-rated questions about tendency to doze during daytime.
e. Other Lifestyle Behaviors – Additional lifestyle behaviors will be assessed using the U.S
Department of Health and Human Services Health Behavior Questionnaire. The other behaviors being
assessed include smoking status, use of alcohol and drugs, and stress.
Body Weight and Composition. Height and body weight of all participants will be measured to calculate
body mass index BMI (kgs/m2). Dual-energy x-ray absorptiometry (DEXA) will be used to estimate body
composition data through the whole body scan. Assessment will take place using the Hologic DELPHIW. The participant will be asked to lie on their back, positioned on the machine according to protocol. They
will be asked to lie completely still, while breathing normally, and closing their eyes while the scan
absorptiometry is in progress. The whole body scan lasts approximately 6 minutes. The DEXA analysis
provides the most accurate method available to assess body composition. According to the manufacture’s
specifications (i.e., Hologic Inc.), whole body DXA analysis exposes participants to 1.5 mrem of radiation.
The exposure to radiation during a single chest x-ray (i.e., 5 mrem) is more than 3 times greater than
radiation from DEXA. Also, background radiation from DEXA is about equal to the amount of radiation
one experiences during a flight from New York to London. Please note that the effects of the DEXA scan
are cumulative depending on your prior exposure to radiation. If you have questions regarding your risk
from the scan please consult with the investigators.
Time Required:
Total time to complete the test sessions is estimated to be: Test session #1 (Orientation session, 1 hour),
Test session #2 and #4 (1 hour each), and test sessions #3 and 5 (1 hour each). You will be allowed to rest
as long as necessary between exercise testing stations. Participants in the Exercise Group will be asked to
attend 3-4 exercise sessions (45-55 minutes in duration) for 10 weeks. Participants in the Dietary
Intervention will be asked to come to the Human Performance Lab in Godwin once a week (30 minutes) for
a body weight measure, assessment of dietary and beverage intake by 24-hr Food Intake Recall, and dietary
guidance.
Risks:
There is minimal risk associated with exercise testing in individuals who are “low risk” according to
guidelines established by the American College of Sports Medicine. There is a minimal level of discomfort
that may be experienced during the exercise testing, which includes muscle soreness and fatigue. Muscle
soreness may be felt 24-48 hours following the testing.
The risks of venipuncture blood sampling include possible mild bruising and the risk of transfer of bloodborne pathogens. This risk is considered to be minimal, and all safety precautions for handing blood
samples will be followed according to Occupational Health and Safety Administration (OSHA) protocols.
Benefits:
You will receive the results from your individual fitness testing, including a rating of how you compare to
females within your age category. You will also receive information regarding your current risk factors for
cardiovascular disease, Type II diabetes, osteoporosis and cancer.
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Confidentiality:
All data and results will be kept confidential. Participants will be assigned an identification code. At no
time will a participant’s name be identified with individual data. All data will be secured in a locked
cabinet in a locked office. Upon completion of the study, all information that matches up individual
respondents with their answers or fitness test results will be destroyed.
Participation and Withdrawal:
Your participation is entirely voluntary. You are free to choose not to participate. Should you choose to
participate, you can withdraw at any time without consequences of any kind.
Reporting Procedures:
Participants will be provided health and fitness tests data at the completion of each test. The findings of the
study will be presented at regional and national organizations conferences and submitted for publication in
professional journals
Questions about the Study:
If you have questions or concerns during the time of your participation in this study, or after its completion
or you would like to receive a copy of the final aggregate results of this study, please contact:
Dr. Judith A. Flohr, Ph.D
Department of Kinesiology
Morrison Bruce Center for the Promotion of Physical Activity for Girls and Women
James Madison University
flohrja@jmu.edu
540-568-3448
Questions about Your Rights as a Research Subject
Dr. David Cockley
Chair, Institutional Review Board
James Madison University
(540) 568-2834
cocklede@jmu.edu

Giving of Consent
I have read this consent form and I understand what is being requested of me as a participant in this study.
I freely consent to participate. I have been given satisfactory answers to my questions. The investigator
provided me with a copy of this form. I certify that I am at least 18 years of age.
My initials below signify that I agree to participate in the test for the phase(s) I have indicated above.

____________________________________
Name of Participant (Printed)
______________________________________ ______________
Name of Participant (Signed)
Date
____________________________________
Name of Witness (Printed)
______________________________________ ______________
Name of Witness (Signed)
Date
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Appendix II
James Madison University
Department of Kinesiology
Women Atherosclerosis Inflammation and Thrombosis (WAIAT)
Health Status Questionnaire
Instructions: Complete each question accurately. All information provided is confidential.
Part I Demographic Information
1.
ID# ______

Date

2.
Legal Name

Nickname

Mailing Address (Local Address)

Local Phone

Permanent Address (Home)

Phone

3.

4.

5. Gender (circle one)

Male

Female

6. Date of Birth
Month/ Day/ Year
Part II Medical History
7. Circle any that died of heart attack before age 50

Father

8. Date of Last medical exam: ________________
9. Circle operations you have had: Back

Mother Brother Sister

Grandparent

Last physical fitness test: _______________

Heart

Kidney Eyes

Lung

Other

Joint

Neck

Ears

Hernia

10. Please circle any of the following for which you have been diagnosed of treated by a physician or
health professional:
Alcoholism
Anemia (sickle cell)
Anemia (other)
Asthma
Back Strain
Bleeding trait
Bronchitis, chronic
Cancer
Cirrhosis, liver
Concussion
Congenital defect

Diabetes
Emphysema
Epilepsy
Eye Problems
Gout
Hearing Loss
Heart Problem
High Blood Pressure
Hypoglycemia
Hyperlipidemia
Infectious Mononucleosis

Kidney problems
Mental Illness
Neck Strain
Obesity
Phlebitis
Rheumatoid arthritis
Stroke
Thyroid problem
Ulcer
Other _______________________
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11. Circle all medications taken in the last six months:
Blood thinner
Epilepsy medication
Diabetic pill
Heart-rhythm medication
Digitalis
High-blood pressure medication
Diuretic
Insulin

Nitroglycerin
Other _______________________

12. Any of these health symptoms that occur frequently is the basis for medical attention. Circle the number
indicating how often you have each of the following:
5 = Very often

4 = Fairly often 3 = Sometimes

2 = Infrequently 1 = practically never

a. cough up blood
1 2 3 4 5

f. chest pain
1 2 3 4 5

b. abdominal pain
1 2 3 4 5

g. swollen joints
1 2 3 4 5

c. low back pain
1 2 3 4 5

h. feels faint
1 2 3 4 5

d. leg pain
1 2 3 4 5

i. Dizziness
1 2 3 4 5

e. arm or shoulder pain
1 2 3 4 5

j. breathless on slight exertion
1 2 3 4 5

Part III Health Related Behavior
13. Do you smoke?
Yes

No

14. If you are a smoker, indicate the number smoked per day:
Cigarettes:
40 or more
20-39
Cigars or pipes only: 5 or more or any inhaled
15. Do you exercise regularly?

Yes

10-19
1-9
less than 5, none inhaled
No

16. How many times in a week do you spend at least 20 minutes in moderate to strenuous exercise?
1

2

3

4

5

17. Can you walk 4 miles briskly without fatigue?

6

7

Yes

No

days per week

18. Can you jog 3 miles continuously at a moderate pace without discomfort?
19. Weight now: __________ lb.

One year ago: __________ lb.

Yes

No

Age 21: __________ lb.

Source: Howley and Franks. (2007). Health Fitness Instructor’s Handbook. Health Status Questionnaire.
Champaign: Human Kinetics.
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Appendix III
James Madison University
Department of Kinesiology
Women Atherosclerosis Inflammation and Thrombosis (WAIAT)
Physical Activity Readiness Questionnaire
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Appendix IV
James Madison University
Department of Kinesiology
Women Atherosclerosis Inflammation and Thrombosis (WAIAT)
Food Intake Record
Name:_________________
Date:_______________
Notes:_____________________________________________
Time

Location

DETAILED Description (Be as detailed
as possible in describing the food item.
For example not just chicken, but how
it’s cooked (fried, grilled, baked, etc),
and include any sauces or dressings put
on any food item. Remember beverages
too.)

Day: 1 2 3 (circle one)

Amount
EATEN
(be
specific)

User Notes
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Appendix V
James Madison University
Department of Kinesiology
Women Atherosclerosis Inflammation and Thrombosis (WAIAT)
Maximal Oxygen Consumption Data

Study ID # ___________
Date ___________________ Time of Day
__________________
Height _____(in) _____(cm) Weight _____(lb) _____(kg) Date of Birth
__________________
Age ________________
Resting HR _____________bpm
Resting BP
_______/_______mmHg
Modified Balke Protocol
Time
Speed
Grade
Heart
VO2
VCO2 RPE
Comments
(min)
(mph)
(%)
Rate
L/min
L/min
WU 1
2-3
0%
WU 2
2-3
WU 3
2-3
WU 4
2-3
WU 5
2-3
E1
3.0
3%
E2
3.0
E3
3.0
6%
E4
3.0
E5
3.0
9%
E6
3.0
E7
3.0
12%
E8
3.0
E9
3.0
15%
E 10
3.0
E 11
3.3
15%
E 12
3.3
E 13
3.6
15%
E 14
3.6
E 15
3.9
15%
E 16
3.9
CD 1
3.0
CD 2
3.0
0%
CD 3
3.0
CD 4
3.0
CD 5
3.0
VO2 Max(L/min): ___________ VO2 Max(mL/min):___________RER:
________________
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